Vimarsana
Biggest News Aggregation in the World

Page 2 - Research Infrastructure Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Infrastructure Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Infrastructure Programs Today - Breaking & Trending Today

Open Grant Calls to boost the fight against HIV/AIDS - Vimarsana News

Open Grant Calls to boost the fight against HIV/AIDS

A list of open funding opportunities for NGOs worldwide working for HIV/AIDS Prevention and continuously supporting HIV-infected people. Youth Hub Seed

Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail AR-701 Is Protective in Non-Human Primates - Vimarsana News

Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail AR-701 Is Protective in Non-Human Primates

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...

University of Minnesota receives $66 million to establish new antiviral drug discovery center - Vimarsana News

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

U of M receives NIAID grant to develop drug treatments for future viral pandemics - Vimarsana News

U of M receives NIAID grant to develop drug treatments for future viral pandemics

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern - Vimarsana News

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.